Presentation is loading. Please wait.

Presentation is loading. Please wait.

Allele-Specific, Non-Extendable Primer Blocker PCR (AS-NEPB-PCR) for DNA Mutation Detection in Cancer  Haiying Wang, John Jiang, Bianca Mostert, Anieta.

Published byIrmak Deliktaş Modified over 5 years ago

Similar presentations

Presentation on theme: "Allele-Specific, Non-Extendable Primer Blocker PCR (AS-NEPB-PCR) for DNA Mutation Detection in Cancer  Haiying Wang, John Jiang, Bianca Mostert, Anieta."— Presentation transcript:

1 Allele-Specific, Non-Extendable Primer Blocker PCR (AS-NEPB-PCR) for DNA Mutation Detection in Cancer  Haiying Wang, John Jiang, Bianca Mostert, Anieta Sieuwerts, John W.M. Martens, Stefan Sleijfer, John A. Foekens, Yixin Wang  The Journal of Molecular Diagnostics  Volume 15, Issue 1, Pages (January 2013) DOI: /j.jmoldx Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

2 Figure 1 Diagram for NEPB design. Primer with 3′ end modifications (eg, phosphate, inverted dT, or amino-C7) functions as a blocking group to prevent DNA polymerase extension on wild-type (WT) sequence. Real-time AS-PCR amplifies only allele-specific (AS) primed mutation, whereas WT is blocked by the modified non-extendable primer blocker (NEPB). The Journal of Molecular Diagnostics  , 62-69DOI: ( /j.jmoldx ) Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

3 Figure 2 PCR product detected by gel electrophoresis: equal amounts of PCR products were loaded on the gel. Single sharp bands were observed from 5% to 0.1% mutant-containing reactions, and no PCR products were observed from the wild-type–only reactions. Actin was used as the control. A: B-Raf assay. Lane 1: 100-bp Molecular weight marker. Lanes 2–7: NEPB: HT29 cell line 5%, 1%, 0.5%, 0.1%, SKBR3, and no template control (NTC). Lanes 8–12: Actin control: HT29_1%, 0.5%, 0.1%, SKBR3 and NTC. B: K-Ras P4 (G12V; G>T) assay. Lane 1: 100-bp Molecular weight marker. Lanes 2–4: No blocker: SW480 cell line 0.1%, wild-type (WT) and NTC. Lanes 5–7: NEPB: SW %, WT, and NTC. Lanes 8–10: BP: SW %, WT, and NTC. Lanes 11 and 12: Actin control: SW % and WT. C: K-Ras P7 (G13D; 13G>A) assay. Lane 1: 100-bp Molecular weight marker. Lanes 2–4: No blocker: HCT116 cell line 0.1%, WT, and NTC; Lanes 5–7: NEPB: HCT %, WT and NTC; Lanes 8–10. BP: HCT %, WT, and NTC. Lanes 11 and 12: Actin control: HCT % and WT. D: EGFR (L858R; 2573 T>G) assay. Lane 1: 100-bp Molecular weight marker. Lanes 2–5: No blocker: H1975 cell line 1%, 0.5%, 0.1%, and NCI-H358 cell line (WT). Lanes 6–9: NEPB: H1975 1%, 0.5%, 0.1%, and NCI-H358 (WT). Lanes 10–12: Actin control: NCI-H358 (WT) and NTC. The Journal of Molecular Diagnostics  , 62-69DOI: ( /j.jmoldx ) Copyright © 2013 American Society for Investigative Pathology and the Association for Molecular Pathology Terms and Conditions

Download ppt "Allele-Specific, Non-Extendable Primer Blocker PCR (AS-NEPB-PCR) for DNA Mutation Detection in Cancer  Haiying Wang, John Jiang, Bianca Mostert, Anieta."

Similar presentations

CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.

CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma Carol D. Jones, Katherine H. Darnell, Roger A.
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.

Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
An Enhanced Polymerase Chain Reaction Assay to Detect Pre- and Full Mutation Alleles of the Fragile X Mental Retardation 1 Gene  Alessandro Saluto, Alessandro.

An Enhanced Polymerase Chain Reaction Assay to Detect Pre- and Full Mutation Alleles of the Fragile X Mental Retardation 1 Gene  Alessandro Saluto, Alessandro.
EGFR Mutations in Lung Adenocarcinomas

EGFR Mutations in Lung Adenocarcinomas
Detection of Exon 12 Mutations in the JAK2 Gene

Detection of Exon 12 Mutations in the JAK2 Gene
Mutant Enrichment with 3′-Modified Oligonucleotides

Mutant Enrichment with 3′-Modified Oligonucleotides
One-Step Ligation on RNA Amplification for the Detection of Point Mutations  Lei Zhang, Jingjing Wang, Mia Coetzer, Stephanie Angione, Rami Kantor, Anubhav.

One-Step Ligation on RNA Amplification for the Detection of Point Mutations  Lei Zhang, Jingjing Wang, Mia Coetzer, Stephanie Angione, Rami Kantor, Anubhav.
Detection of Low-Level KRAS Mutations Using PNA-Mediated Asymmetric PCR Clamping and Melting Curve Analysis with Unlabeled Probes  Ji Eun Oh, Hee Sun.

Detection of Low-Level KRAS Mutations Using PNA-Mediated Asymmetric PCR Clamping and Melting Curve Analysis with Unlabeled Probes  Ji Eun Oh, Hee Sun.
Locked Nucleic Acids Can Enhance the Analytical Performance of Quantitative Methylation-Specific Polymerase Chain Reaction  Karen S. Gustafson  The Journal.

Locked Nucleic Acids Can Enhance the Analytical Performance of Quantitative Methylation-Specific Polymerase Chain Reaction  Karen S. Gustafson  The Journal.
Rapid Detection of the Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer for Analysis of Acquired Resistance Using Molecular Beacons 

Rapid Detection of the Epidermal Growth Factor Receptor Mutation in Non-Small-Cell Lung Cancer for Analysis of Acquired Resistance Using Molecular Beacons 
A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk.

A Rapid Polymerase Chain Reaction-Based Screening Method for Identification of All Expanded Alleles of the Fragile X (FMR1) Gene in Newborn and High-Risk.
Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses  Narasimhan Nagan, Nicole E. Faulkner,

Laboratory Guidelines for Detection, Interpretation, and Reporting of Maternal Cell Contamination in Prenatal Analyses  Narasimhan Nagan, Nicole E. Faulkner,
An Alternative Method for Screening EGFR Mutation Using RFLP in Non-small Cell Lung Cancer Patients  Ichiro Kawada, MD, Kenzo Soejima, MD, PhD, Hideo.

An Alternative Method for Screening EGFR Mutation Using RFLP in Non-small Cell Lung Cancer Patients  Ichiro Kawada, MD, Kenzo Soejima, MD, PhD, Hideo.
Suppression of Wild-Type Amplification by Selectivity Enhancing Agents in PCR Assays that Utilize SuperSelective Primers for the Detection of Rare Somatic.

Suppression of Wild-Type Amplification by Selectivity Enhancing Agents in PCR Assays that Utilize SuperSelective Primers for the Detection of Rare Somatic.
Rapid and Simple Detection of Hot Spot Point Mutations of Epidermal Growth Factor Receptor, BRAF, and NRAS in Cancers Using the Loop-Hybrid Mobility Shift.

Rapid and Simple Detection of Hot Spot Point Mutations of Epidermal Growth Factor Receptor, BRAF, and NRAS in Cancers Using the Loop-Hybrid Mobility Shift.
Mutation Spectrum of the Survival of Motor Neuron 1 and Functional Analysis of Variants in Chinese Spinal Muscular Atrophy  Yu-jin Qu, Jin-li Bai, Yan-yan.

Mutation Spectrum of the Survival of Motor Neuron 1 and Functional Analysis of Variants in Chinese Spinal Muscular Atrophy  Yu-jin Qu, Jin-li Bai, Yan-yan.
High-Fidelity DNA Polymerase Enhances the Sensitivity of a Peptide Nucleic Acid Clamp PCR Assay for K-ras Mutations  Bjørnar Gilje, Reino Heikkilä, Satu.

High-Fidelity DNA Polymerase Enhances the Sensitivity of a Peptide Nucleic Acid Clamp PCR Assay for K-ras Mutations  Bjørnar Gilje, Reino Heikkilä, Satu.
Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR  Jennifer.

Multiplex Preamplification of Serum DNA to Facilitate Reliable Detection of Extremely Rare Cancer Mutations in Circulating DNA by Digital PCR  Jennifer.
Joanna Wang, Chetan Bettegowda  The Journal of Molecular Diagnostics 

Joanna Wang, Chetan Bettegowda  The Journal of Molecular Diagnostics 
Philippe Szankasi, Mohamed Jama, David W. Bahler 

Philippe Szankasi, Mohamed Jama, David W. Bahler 

Similar presentations

Ads by Google